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Background: Large population-based databases based on electronic medical records (EMRs) of patients in primary
care are a useful data source to investigate morbidity and health care utilization. Diagnoses recorded in EMRs are
doctor-defined, but their validity can be disputed. In this study we investigated the validity of the diagnosis
inflammatory arthritis (IA), a group of chronic rheumatic diseases, including rheumatoid arthritis, psoriatic arthritis
and ankylosing spondylitis, in primary care based EMRs.
Methods: In five general practices, participating in the Netherlands Information Network of General Practice (LINH),
EMRs of 219 patients with a diagnostic code of IA were systematically reviewed on characteristics which are not
routinely extracted for the LINH database. The diagnosis IA was confirmed when we found, based on a
correspondence with a medical specialist, the following diagnoses in the free text fields of the EMR: oligoarthritis,
polyarthritis, rheumatoid arthritis and/or spondyloarthropathy. These results were used to determine the validity of
the diagnosis IA in EMRs and to develop an algorithm to improve diagnostic validity.
Results: From the 219 patients diagnosed as IA in the database, the diagnosis IA was confirmed in 155 patients
(70.8%). The algorithm, which resulted in a group of patients with as many as possible confirmed IA-diagnosed
patients without excluding too many patients from our dataset, was when patients fulfilled at least one of the
following three criteria: 1) a repeat prescription for a disease-modifying antirheumatic drug (DMARD) and/or
biological agent, 2) ≥ four contacts or one episode with a diagnostic code for IA, combined with at least two
IA-related prescriptions (excluding DMARDs/biological agents), and 3) age at diagnosis ≥ 61 years. After applying
this algorithm, the percentage of correctly diagnosed IA patients increased from 71% to 78% reducing the size of
our study population by 36%.
Conclusions: Based on additional diagnostic information, the diagnosis IA from EMRs of patients in primary care is
sufficiently valid when using the proposed algorithm. After applying the algorithm, the percentage of correctly
diagnosed IA patients increased from 71% to 78%.
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A major advantage of using electronic medical records
(EMRs) from general practitioners (GPs) is the possibil-
ity to study large numbers of patients over a long period.
This makes it, for example, possible to investigate dis-
eases with a low prevalence, or monitor disease course
over time. Furthermore, patients from primary care, in
countries where the GP acts as gatekeeper and where in-
habitants are listed in a practice, are representative for
the total population, including the whole range of dis-
ease severity. Cohorts in secondary care often contain
only patients with more severe disease-stage, which
makes it, compared with primary care, more difficult to
generalize results to the total patient population. Finally,
in case of fixed patient lists, control patients can be eas-
ily selected for case–control studies from the same prac-
tice as the cases, which diminishes the possible bias due
to practice variation.
In the Netherlands, all inhabitants are listed with a
general practice and generally the GP is the first profes-
sional to be consulted for health problems. As in many
countries, GPs have a gatekeeper role for access to
specialized care, and therefore their EMRs include a
complete record of all morbidity of their patients using a
uniform methodology. According to the guidelines of
the Dutch College of GPs, GPs are expected to record
diagnostic information from their patients routinely in
EMRs, using the International Classification of Primary
Care version 1 (ICPC-1) [1].
Despite these advantages, the use of EMRs from GPs
for medical research has a number of disadvantages.
First, EMRs only contain routinely recorded information
about patients who visited their GP for complaints and
data are usually not collected in a systematic way. For
many patients, who do not visit their GP on a regular
basis, risk factors such as smoking status, body mass
index or family history of cardiovascular diseases are un-
known. Secondly, the diagnoses of diseases, although
doctor-defined, are not always valid. It is likely that diag-
noses of chronic diseases that are mainly treated by a
GP or diseases that are easily identified, for example
with a diagnostic test with a high sensitivity, like diabetes
mellitus or chronic obstructive pulmonary disease, are
sufficiently valid within an EMR of a GP. However, for
diseases with a less clear diagnostic test or diseases
which could be easily mixed up with other diseases, the
diagnosis is not always correct.
Inflammatory arthritis (IA), defined as a group of
chronic rheumatic diseases, including rheumatoid ar-
thritis, psoriatic arthritis and ankylosing spondylitis, is
an example of a difficult diagnosis to make. Moreover,
it can be difficult for a GP to distinguish IA from
other rheumatic diseases like osteoarthritis (OA) and
gout at disease onset. Therefore, it is expected that aregistered IA diagnosis in an EMR of the GP is not al-
ways valid.
When carrying out studies in IA patients, such a study
will only provide reliable information if the validity of
the diagnosis can be confirmed. The aim of this study is
therefore 1) to investigate the validity of the diagnosis IA
in primary care based records and 2) to develop an algo-
rithm to improve the validity of this diagnosis.Methods
Study population
The database of the Netherlands Information Network
of General Practice (LINH) includes routinely extracted
data from EMRs from on average 85 general practices
with about 350,000 listed patients since 2001 (www.linh.nl).
Five general practices participating in LINH were visited
in 2011 to collect extra diagnostic information. We
selected practices which were representative for all
LINH practices in terms of degree of urbanisation, since
patient populations can differ between a small town and
a large city. In these general practices, all patients of
30 years and older who were ever registered between
2001 and 2010 with a diagnostic code of IA (ICPC-1
code L88) in the LINH database in 2010 were syste-
matically reviewed on characteristics which are not
routinely extracted for the LINH database: free text re-
garding contacts, prescriptions, medical history, refer-
rals and correspondence with medical specialists. The
studied population included incident as well as preva-
lent cases with the whole range of disease duration.
Only patients of 30 years and older were included in the
study to exclude patients with juvenile arthritis.
The study was carried out according to Dutch legislation
on privacy. The privacy regulation of the study is approved
by the Dutch Data Protection Authority. According to
Dutch legislation, neither obtaining informed consent nor
approval by a medical ethics committee was obligatory for
observational studies. In concordance with the GPs, EMRs
were reviewed in the participating practices and data were
analysed anonymously.Validity of the diagnosis inflammatory arthritis
The diagnosis IA was confirmed when we found, based
on a correspondence with a medical specialist, the fol-
lowing diagnoses in the free text fields of the EMR:
oligoarthritis, polyarthritis, rheumatoid arthritis and/or
spondyloarthropathy. Charts were reviewed manually
and systematically for letters from medical specialists
and other correspondence (for instance by telephone) in
the free text fields. The validity of the diagnosis IA in
EMRs was determined by calculating the percentage of
patients in whom the diagnosis IA was confirmed after
chart review.
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Since we expected that a registered IA diagnosis in an
EMR of the GP is not always valid, an algorithm was de-
veloped to improve the validity of the diagnosis IA in
the LINH database. All routinely available information
in our database was used to develop this algorithm to
distinguish IA from non-IA in patients with an ICPC-1
code L88, including the following parameters: age, gen-
der, number of L88-related visits or an L88-related epi-
sode with the GP, prescriptions with the IA diagnostic
code (excluding DMARDs and biological agents) and re-
peat prescriptions of disease-modifying antirheumatic
drugs (DMARDs) and/or biological agents. A disease
episode is the period between the first and last contact
of the patient with the GP for a specific health problem,
which can include multiple contacts. A repeat prescrip-
tion is defined as a prescription issued without a con-
sultation with the GP. In general, a medical specialist
prescribes a DMARD, which is not recorded in the EMR
of the GP, which can be followed by a repeat prescrip-
tion by the GP. Based on these available parameters, we
defined three criteria. The first criterion was the use of
IA medication, defined as ‘a repeat prescription for a
disease-modifying antirheumatic drug (DMARD) or bio-
logical agent’. The second criterion was based on IA-
related consultations and prescriptions, defined as ‘at
least four contacts or one episode with a diagnostic code
for IA (L88), combined with at least two prescriptions
with the IA diagnostic code (excluding DMARDs/bio-
logical agents)’. Finally, the third criterion was based on
age at the time of diagnosis (i.e. age at the moment of
the first L88-coded consultation). The cut-off for ageTable 1 Number of L88-coded patients in the LINH database
distinguish IA from non-IA (n=219)
Numb
who
Without using an algorithm
Algorithm based on one criterion:
Criterion 1: Repeat prescription DMARDs/biological agents
Criterion 2: Contact with GP and IA-related prescription1
Criterion 3: Age 30–61 years at first diagnosis
Algorithm based on two criteria:
Criterion 1 or 2
Criterion 1 or 3
Criterion 2 or 3
Algorithm based on three criteria:
All 3 criteria
2 out of 3 criteria
1 out of 3 criteria
1 ≥ 4 L88 ICPC-1 codes at a contact and ≥ 2 L88 ICPC-1 codes at a prescription ORwas set at 61 years old, since this was the mean age at
time of diagnosis. Patients above 61 years old were more
likely to have other diagnoses than IA, such as osteo-
arthritis. These three criteria were used to develop an al-
gorithm to define a group of patients with as many as
possible confirmed IA-diagnosed patients without ex-
cluding the majority of the patients from our dataset in-
cluding many with an IA diagnosis.
Results
In the five participating general practices, 219 patients
were identified with a recorded IA diagnosis (ICPC-1
code L88) in the LINH database. At the time of the first
contact with ICPC-1 code L88, their mean age was
58 years (SD=15) and 64% was female. The diagnosis IA
was confirmed after chart review in 155 patients (70.8%).
Three criteria were used to develop an algorithm to
define a group of patients with as many as possible con-
firmed IA-diagnosed patients without excluding too
many patients from our dataset: 1) a repeat prescription
for a DMARD and/or biological agent, 2) ≥ four contacts
or one episode with a diagnostic code for IA, combined
with at least two IA-related prescriptions (excluding
DMARDs/biological agents), and 3) age at diagnosis
≤ 61 years. The combination of consultations and pre-
scriptions resulted in the highest percentage confirmed
IA diagnoses. The number of L88-coded patients in the
LINH database who fulfilled each criterion and all com-
binations of these criteria are shown in Table 1.
Applying criterion 1 resulted in a population with the
highest number of patients with a confirmed IA diagnosis
(91.5%), but the lowest number of included patients
(21.5%). On the other hand, using criterion 3 increases thewho fulfilled combinations of criteria of the algorithm to
er of patients (n=219)
fulfilled criteria (%)
Confirmed diagnosis of IA?
Yes No
— 155 (70.8%) 64
47 (21.5%) 43 (91.5%) 4
49 (22.4%) 44 (89.8%) 5
105 (47.9%) 80 (76.2%) 25
73 (33.3%) 64 (87.7%) 9
127 (58.0%) 101 (79.5%) 26
132 (60.3%) 102 (77.3%) 30
9 (4.1%) 9 (100%) 0
52 (23.7%) 49 (94.2%) 3
140 (63.9%) 109 (77.9%) 31
≥ 1 L88 ICPC-1 code at an episode and ≥ 2 L88 ICPC-1 codes at a prescription.
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number of patients with a confirmed IA diagnosis (76.2%).
Combining two of the three defined criteria, resulted in
general in lower validity of the IA diagnosis (i.e. lower
number of confirmed IA diagnoses), but a higher number
of patients who fulfil the criteria, compared with using
only one criterion. Validity varied between 77.3% and
87.7% with 33.3% to 60.3% included patients. Finally, using
all three criteria in an algorithm resulted in 100% validity
when patients needed to fulfil all three criteria. However,
only 9 out of 219 patients (4.1%) fulfilled all three criteria.
The algorithm, which resulted in a group of patients with
as many as possible confirmed IA-diagnosed patients
without excluding too many patients from our dataset,
was when patients fulfilled at least one of the three cri-
teria. Applying this algorithm resulted in a group of 140
patients (excluding 36.1% of all patients) with a validity of
the diagnosis IA of 78%.Discussion
After chart review, the diagnosis IA from EMRs of 219
patients was confirmed in 155 patients (71%). All rou-
tinely available information in our database was used to
develop an algorithm to identify IA patients. After apply-
ing the algorithm, the percentage of correctly diagnosed
IA patients increased from 71% to 78%.
To our knowledge this is the first validation study of
the diagnosis inflammatory arthritis in EMRs from GPs.
The validity of the diagnosis rheumatoid arthritis, based
on other classification systems, such as the International
Classification of Diseases (ICD), has already been deter-
mined in several cohorts [2-5]. These studies showed
sufficient validity of the diagnosis, especially after using
algorithms to define patients who are most likely to have
the diagnosis of a rheumatic disease; the range between
72% and 91% is in line with our results. In a systematic
review, Herrett et al. studied the validity of 183 different
diagnoses in primary care and found a median of 80%
confirmed diagnoses in the group musculoskeletal disor-
ders [6]. This is in line with the results of our study after
applying our algorithm.
After applying our algorithm, in about 20% of the pa-
tient group with a recorded IA diagnosis this could not
be confirmed. In these patients, besides an ICPC-1 L88-
related contact, no additional information was found in
the free text fields regarding contacts, prescriptions,
medical history, referrals and correspondence with med-
ical specialists to confirm the diagnosis IA. The diagno-
sis IA could have been registered once due to suspicion
for a rheumatic disease and changed later in a diagnosis
gout or osteoarthritis. Despite this percentage of false
positives, we think that EMRs from GPs are still a useful
data source with sufficient power for studying morbidityand health care utilization in IA or OA patients. More-
over, it is often clear in which direction results are
biased when including a small proportion with less se-
vere diseases. Including patients without an IA diagnosis
into the study population will result in an overestimation
of both the incidence and prevalence rates of IA. On the
other hand, comorbidity and health care utilization will
be underestimated. Patients without a diagnosis IA are
less likely to develop comorbidity or to use certain medi-
cation, resulting in lower rates compared with non-
biased study populations. This limitation should always
be discussed together with the advantages of using
EMRs for medical research, such as the use of large pa-
tient groups and having a representative study popula-
tion with the whole range of disease severity.
This study has some limitations. First, we used a sam-
ple of patients from just five general practices. We did
not validate our algorithm in another set of general prac-
tices. Second, the diagnosis of the medical specialist was
used as gold standard. It is unclear to what extent med-
ical specialists made wrong diagnoses. Moreover, we
only sought to confirm the IA diagnosis recorded by the
GP; the number of true IA patients without a diagnosis
IA (false negatives) in the EMRs of the GP was not
established. Finally, given the low percentage of patients
who did fulfil the first criterion of the algorithm, it is
likely that a number of DMARD users is incorrectly ex-
cluded. A DMARD is, in most cases, prescribed by a
rheumatologist, followed by a repeat prescription of the
GP. These repeat prescriptions are not always registered
in the EMR of the GP. Since DMARD users are the
more severe IA patients, it is expected that these pa-
tients fulfil the second criterion of our algorithm, includ-
ing GP consultations and prescriptions.Conclusions
Based on additional diagnostic information, the diagno-
sis IA from EMRs of patients in primary care is suffi-
ciently valid when using the proposed algorithm. After
applying the algorithm, the percentage of correctly diag-
nosed IA patients increased from 71% to 78%.
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